Distinguishing Microvasculature Features of Vogt-Koyanagi-Harada in Patients in Acute and Convalescent Phases Using Optical Coherence Tomography Angiography

References

• Algahtani H, Shirah B, Algahtani R, Alkahtani A, Alwadie S Vogt Koyanagi Harada syndrome mimicking multiple sclerosis: a case report and review of the literature. Mult Scler Relat Disord. 2017;12:44–48. doi: 10.1016/j.msard.2017.01.003
   Google Scholar
• Yang P, Zhong Y, Du L, et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136(9):1025–1031. doi:10.1001/jamaophthalmol.2018.2664.
   PubMed Web of Science ®Google Scholar
• Tubridy N, Redmond J, O’Connor M. Vogt Koyanagi Harada (VKH) syndrome. Ir Med J. 1996;89:53.
   PubMedGoogle Scholar
• Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292. doi:10.1016/S0039-6257(05)80105-5.
   PubMed Web of Science ®Google Scholar
• Huang G, Peng J, Ye Z, Kijlstra A, Zhang D, Yang P. Multispectral image analysis in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2018;96(4):411–419. doi:10.1111/aos.2018.96.issue-4.
   PubMed Web of Science ®Google Scholar
• Chalam KV, Sambhav K. Optical coherence tomography angiography in retinal diseases. J Ophthalmic Vis Res. 2016;11(1):84–92. doi:10.4103/2008-322X.180709.
   PubMedGoogle Scholar
• Told R, Ginner L, Hecht A, et al. Comparative study between a spectral domain and a high-speed single-beam swept source OCTA system for identifying choroidal neovascularization in AMD. Sci Rep. 2016;6:38132. doi:10.1038/srep38132.
   PubMed Web of Science ®Google Scholar
• Henke S, Papapostolou I, Heimes B, Lommatzsch A, Pauleikhoff D, Spital G. OCT-angiography in diabetic maculopathy: comparison between microaneurysms and the foveal avascular zone with flourescein angiography. Ophthalmologe. 2018;115(11):941–947. doi:10.1007/s00347-017-0605-9.
   PubMed Web of Science ®Google Scholar
• Aggarwal K, Agarwal A, Mahajan S, et al. The role of optical coherence tomography angiography in the diagnosis and management of acute Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2018;26(1):142–153. doi:10.1080/09273948.2016.1195001.
   PubMed Web of Science ®Google Scholar
• Aggarwal K, Agarwal A, Deokar A, et al. Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. J Ophthalmic Inflamm Infect. 2017;7(1):3.
   PubMed Web of Science ®Google Scholar
• Tan ACS, Tan GS, Denniston AK, et al. An overview of the clinical applications of optical coherence tomography angiography. Eye (Lond). 2018;32(2):262–286. doi:10.1038/eye.2017.181.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Chen CL, Gahm JK, et al. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66–100. doi:10.1016/j.preteyeres.2017.07.002.
   PubMed Web of Science ®Google Scholar
• Lee J, Rosen R. Optical coherence tomography angiography in diabetes. Curr Diab Rep. 2016;16(12):123. doi:10.1007/s11892-016-0811-x.
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652. doi:10.1016/S0002-9394(01)00925-4.
   PubMed Web of Science ®Google Scholar
• Read RW, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2006;142(1):119–124. doi:10.1016/j.ajo.2006.02.049.
   PubMed Web of Science ®Google Scholar
• Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Vogt-Koyanagi-Harada  disease:  clinical  outcomes.  Am  J Ophthalmol. 2005;140(4):674–678.
   Google Scholar
• Lodhi SA, Reddy JL, Peram V. Clinical spectrum and management options in Vogt-Koyanagi-Harada disease. D - 101321512. (- 1177-5467 (Print)):- 1399–1406. doi: 10.2147/OPTH.S134977
   Google Scholar
• Rubsamen PE, Gass JDM. Vogt-Koyanagi-Harada Syndrome: clinical course, therapy, and long-term visual outcome. JAMA Ophthalmol. 1991;109:682–687.
   Google Scholar
• Spaide RF, Klancnik JM Jr., Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50. doi:10.1001/jamaophthalmol.2014.3616.
   PubMed Web of Science ®Google Scholar
• Abano JM, Galvante PR, Siopongco P, Dans K, Lopez J. Review of epidemiology of uveitis in Asia: pattern of uveitis in a tertiary hospital in the Philippines. Ocul Immunol Inflamm. 2017;25(sup1):S75–S80. doi:10.1080/09273948.2017.1335755.
   PubMed Web of Science ®Google Scholar
• Li S, Yang P. Uveitis in China. Ocul Immunol Inflamm. 1994;2(4):247–252. doi:10.3109/09273949409057083.
   PubMedGoogle Scholar
• Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30(11):943–948. doi:10.1080/02713680500263606.
   PubMed Web of Science ®Google Scholar
• Fang W, Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res. 2008;33(7):517–523. doi:10.1080/02713680802233968.
   PubMed Web of Science ®Google Scholar
• Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119(5):1218–1224. doi:10.1016/j.jaci.2007.01.010.
   PubMed Web of Science ®Google Scholar
• Damico FM, Bezerra FT, Silva GC, Gasparin F, Yamamoto JH. New insights into Vogt-Koyanagi-Harada disease. Arq Bras Oftalmol. 2009;72(3):413–420. doi:10.1590/S0004-27492009000300028.
   PubMed Web of Science ®Google Scholar
• Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina (Philadelphia, Pa). 2011;31(3):502–509. doi:10.1097/IAE.0b013e3182083beb.
   PubMed Web of Science ®Google Scholar
• Mawatari Y, Hirata A, Fukushima M, Tanihara H. Choroidal dye filling velocity in patients with Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):1056–1059. doi:10.1007/s00417-005-0238-6.
   PubMed Web of Science ®Google Scholar
• Brancato R, Trabucchi G. Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol. 1998;13(4):189–198. doi:10.3109/08820539809056052.
   PubMedGoogle Scholar
• Novais EA, Roisman L, de Oliveira PR, et al. Optical coherence tomography angiography of chorioretinal diseases. Ophthalmic Surg Lasers Imaging Retina. 2016;47(9):848–861.
   PubMed Web of Science ®Google Scholar
• Giannakouras P, Andreanos K, Giavi B, Diagourtas A. Optical coherence tomography angiography: employing a novel technique for investigation in Vogt-Koyanagi-Harada disease. Case Rep Ophthalmol. 2017;8(2):362–369. doi:10.1159/000477611.
   PubMed Web of Science ®Google Scholar
• Jia SS, Zhao C, Gong D, Chen Z, Zhang MF. Optical coherence tomography angiography of acute Vogt-Koyanagi-Harada disease. Zhonghua Yan Ke Za Zhi. 2017;53(10):735–739. doi:10.3760/cma.j.issn.0412-4081.2017.10.004.
   PubMedGoogle Scholar